Journal profile · Biochemistry, Genetics and Molecular Biology-Genetics
Molecular Genetics & Genomic Medicine
ISSN 2324-9269 · John Wiley and Sons Inc. · United States
Molecular Genetics & Genomic Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.57; fully open access; APC about USD 3,040; median 181 days to acceptance (94 articles, last 24 months); acceptance rate 9% (journal website); 150 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Molecular Genetics & Genomic Medicine is published by John Wiley and Sons Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Genomics and Rare Diseases, Genomic variations and chromosomal abnormalities and Connective tissue disorders research, together about 32.9% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Molecular Genetics & Genomic Medicine is a peer-reviewed journal for rapid dissemination of quality research related to the dynamically developing areas of human, molecular and medical genetics. The journal publishes original research articles covering findings in phenotypic, molecular, biological, and genomic aspects of genomic variation, inherited disorders and birth defects. The broad publishing spectrum of Molecular Genetics & Genomic Medicine includes rare and common disorders from diagnosis to treatment. Examples of appropriate articles include reports of novel disease genes, functional studies of genetic variants, in-depth genotype-phenotype studies, genomic analysis of inherited disorders, molecular diagnostic methods, medical bioinformatics, ethical, legal, and social implications (ELSI), and approaches to clinical diagnosis. Molecular Genetics & Genomic Medicine provides a scientific home for next generation sequencing studies of rare and common disorders, which will make research in this fascinating area easily and rapidly accessible to the scientific community. This will serve as the basis for translating next generation sequencing studies into individualized diagnostics and therapeutics, for day-to-day medical care. Molecular Genetics & Genomic Medicine publishes original research articles, reviews, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented. Simple, purely descriptive, single-patient Case Reports are out of scope for this journal. For such Case Reports we recommend considering submission to Case Reports in Genetics. Note: This journal does not consider studies involving forensic genetic analysis.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Genetics
Editor-in-chief Paraminder DhillonPublisher website
Editorial board by country: none in mainland China; most named United States 5, India 4, United Kingdom 2, France 1, Canada 1 (21 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology17.7%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology9.2%
- Connective tissue disorders researchBiochemistry, Genetics and Molecular Biology6%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology5.5%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology4.1%
- Prenatal Screening and DiagnosticsMedicine3.8%
- Congenital heart defects researchBiochemistry, Genetics and Molecular Biology3.8%
- Genetic Syndromes and ImprintingBiochemistry, Genetics and Molecular Biology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCCASPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.57LetPub ·
- Impact factor (publisher)
- 1.6Publisher website ·
- Impact factor (publisher) 2025
- 1.6Publisher website ·
- CiteScore 2026-06
- 3.1LetPub ·
- CiteScore (publisher)
- 3.1Publisher website ·
- CiteScore (publisher) 2025
- 3.1Publisher website ·
- SJR 2026-06
- 0.6LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 2LetPub ·
- h-index
- 58OpenAlex ·
- i10-index
- 1,171OpenAlex ·
- 2-year mean citedness
- 1.48OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.8%LetPub ·
Volume
- Articles per year
- 122LetPub ·
- Articles per year (publisher) 2025
- 123Publisher website ·
- Downloads per year (publisher) 2025
- 643,121Publisher website ·
Articles by year OpenAlex count · 2,898 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 130 | 130 | 11 |
| 2025 | 150 | 150 | 156 |
| 2024 | 218 | 218 | 571 |
| 2023 | 231 | 231 | 1,132 |
| 2022 | 275 | 275 | 2,097 |
| 2021 | 285 | 285 | 2,759 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
181 daysMedian, submission to acceptance · P25–P75 119 days – 250 days
- Acceptance to online
- median 13 days (94 articles)
- Submission to online
- median 206 days
- Sample
- 94 articles with submission and acceptance dates (294 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Acceptance rate (publisher)
- 9%Publisher website ·
- Acceptance rate (publisher) 2025
- 9%Publisher website ·
- Submission to first decision
- 11 daysPublisher website ·
- Submission to first decision 2025
- 11 daysPublisher website ·
- Submission to acceptance 2025
- 173 daysPublisher website ·
- Acceptance to publication 2025
- 14 daysPublisher website ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,040 / GBP 1,880 / EUR 2,240 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,900 / EUR 2,140 / GBP 1,880 | — | — | |
| LetPub | USD 2,700 / GBP 1,750 / EUR 2,000 | Yes | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 200 words
- Keywords
- 3–5
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Self-archiving, Trial registration / reporting guidelines
- Authorship Author contributions (CRediT)
This journal requires details of all authors' contributions to the work by providing CRediT (Contribution Roles Taxonomy) information during submission.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the Conflict of Interest section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Molecular Genetics & Genomic Medicine encourages data sharing wherever possible, unless this is prevented by ethical, privacy, or confidentiality matters. Authors publishing in the journal are therefore encouraged to make their data, scripts, and other artefacts used to generate the analyses presented in the paper available via a publicly available data repository; however, this is not mandatory. …
Source ↗Publisher website ·- Publication ethics Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- License & copyright For authors signing the copyright transfer agreement
If the open access option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs.
Source ↗Publisher website ·- Open access For authors choosing open access
If the open access option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Papers will only be sent to review if the Editors determine that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Self-archiving Self-Archiving Definitions and Policies
Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers are included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the Abstract. If the trial is not registered, or was registered retrospectively, the…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Inc.
- Country or region
- United States
- Language
- English
- ISSN
- 2324-9269
- Latest issue on the website
- Volume 14, Issue 9 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Molecular Genetics & Genomic Medicine
What CAS zone is Molecular Genetics & Genomic Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Molecular Genetics & Genomic Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Molecular Genetics & Genomic Medicine?
The latest impact factor listed by LetPub is 1.57; CiteScore 3.1, h-index 58.
How long does peer review take at Molecular Genetics & Genomic Medicine?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 181 days (interquartile range 119–250 days); authors report an average review time of about 14 weeks; the journal's website gives an acceptance rate of 9% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Molecular Genetics & Genomic Medicine?
According to the journal's author guidelines: Abstract: ≤ 200 words; Keywords: 3–5; Reference style: Author–date; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Molecular Genetics & Genomic Medicine based?
Of the 21 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (5), India (4) and United Kingdom (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Molecular Genetics & Genomic Medicine?
According to LetPub and DOAJ records, Molecular Genetics & Genomic Medicine is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PMC and CAS; that list has not been checked against each database.
Is Molecular Genetics & Genomic Medicine open access, and what is the APC?
Molecular Genetics & Genomic Medicine is a fully open-access journal. APC about USD 3,040.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .